Journey Medical Corp. (DERM)
6.31
+0.36
(+6.05%)
USD |
NASDAQ |
Oct 09, 16:00
6.29
-0.02
(-0.32%)
After-Hours: 20:00
Journey Medical EPS Diluted (Quarterly) : -0.0114 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0114 |
| March 31, 2026 | -0.0817 |
| December 31, 2025 | -0.0459 |
| September 30, 2025 | -0.0928 |
| June 30, 2025 | -0.163 |
| March 31, 2025 | -0.1801 |
| December 31, 2024 | 0.0687 |
| September 30, 2024 | -0.1164 |
| June 30, 2024 | -0.1681 |
| March 31, 2024 | -0.5285 |
| December 31, 2023 | -0.1109 |
| September 30, 2023 | 0.7982 |
| June 30, 2023 | -0.4645 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.5692 |
| December 31, 2022 | -0.6002 |
| September 30, 2022 | -0.5721 |
| June 30, 2022 | -0.4313 |
| March 31, 2022 | -0.0796 |
| December 31, 2021 | -1.256 |
| September 30, 2021 | -0.639 |
| June 30, 2021 | -0.7122 |
| March 31, 2021 | 0.0161 |
| December 31, 2020 | 0.1502 |
| September 30, 2020 | 0.0017 |
| June 30, 2020 | 0.0273 |
| March 31, 2020 | 0.1379 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.312M |
| Revenue (Quarterly) | 18.51M |
| Total Expenses (Quarterly) | 18.82M |
| Enterprise Value | 174.41M |
| Gross Profit Margin (Quarterly) | 61.58% |
| Profit Margin (Quarterly) | -1.69% |
| Earnings Yield | -3.67% |
| Normalized Earnings Yield | -3.672 |